Oracle
ORCL
Apple
AAPL
D.R. Horton
DHI
Adobe
ADBE
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 21.230
- -0.750-3.41%
Close Feb 24 16:00 ET
- 21.230
- 0.0000.00%
Pre 08:02 ET
1.88BMarket Cap-5.20P/E (TTM)
22.060High20.565Low1.70MVolume22.060Open21.980Pre Close36.12MTurnover2.25%Turnover RatioLossP/E (Static)88.74MShares25.29052wk High31.88P/B1.60BFloat Cap5.12052wk Low--Dividend TTM75.50MShs Float37.040Historical High--Div YieldTTM6.80%Amplitude0.000Historical Low21.299Avg Price1Lot Size
Travere Therapeutic Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.30%-230.02M | 55.52%-28.63M | 42.82%-42.56M | 59.41%-39.83M | -34.60%-119.01M | -24.73%-325.36M | 16.08%-64.37M | 19.11%-74.43M | -166.64%-98.14M | -59.83%-88.42M |
| Net income from continuing operations | 14.80%-320.63M | 31.97%-60.27M | 38.65%-54.75M | 37.99%-69.55M | -57.60%-136.06M | -13.54%-376.33M | -3.46%-88.6M | 13.21%-89.24M | -67.33%-112.17M | -13.64%-86.33M |
| Depreciation and amortization | 13.04%43.56M | 27.43%12.09M | -2.06%11.24M | -5.50%10.35M | 49.24%9.88M | 85.96%38.53M | 50.32%9.49M | 1,547.04%11.48M | 35.01%10.95M | -6.66%6.62M |
| Other non cash items | 4,024.21%74.87M | 18.94%4.65M | 2,200.94%64.88M | 155.84%4.99M | -94.13%364K | -164.29%-1.91M | 262.18%3.91M | 62.99%-3.09M | -293.98%-8.93M | -31.97%6.2M |
| Change In working capital | -147.38%-63.02M | 4.22%7.4M | -37.65%-6.74M | -819.98%-60.74M | 86.02%-2.95M | -3,011.43%-25.48M | 265.76%7.1M | -139.17%-4.9M | -265.75%-6.6M | -86.18%-21.08M |
| -Change in receivables | 46.53%-6.04M | 74.70%-2.03M | -193.12%-731K | -400.87%-1.74M | 66.79%-1.55M | -687.94%-11.3M | -25.49%-8M | -86.28%785K | 128.64%578K | -475.34%-4.66M |
| -Change in inventory | 90.43%-3.77M | 98.73%-285K | 94.84%-246K | 87.95%-1.42M | -257.65%-1.82M | -3,160.55%-39.42M | -59,028.95%-22.39M | -686.22%-4.77M | -517.50%-11.75M | -224.84%-510K |
| -Change in prepaid assets | 32.06%-3.16M | 781.96%1.74M | 37.27%-3.05M | -71.62%866K | -4.81%-2.72M | 10.37%-4.66M | 90.20%-255K | -1,788.72%-4.85M | 202.25%3.05M | -501.08%-2.6M |
| -Change in payables and accrued expense | -203.27%-48.62M | -79.91%8.74M | -107.33%-554K | -1,120.74%-53.45M | 63.52%-3.37M | 94.27%47.08M | 416.48%43.52M | -21.73%7.56M | -65.49%5.24M | -2.34%-9.23M |
| -Change in other current liabilities | 1,450.72%5.65M | -7.76%737K | -2.48%-248K | -290.91%-2.88M | 3,477.31%8.04M | 74.02%-418K | 56.67%799K | -3,125.00%-242K | -209.66%-737K | 87.40%-238K |
| -Change in other working capital | 57.86%-7.07M | 77.03%-1.51M | 43.32%-1.91M | 28.80%-2.12M | 60.41%-1.52M | -20.50%-16.77M | -53.50%-6.57M | 1.95%-3.38M | 26.37%-2.98M | -79.12%-3.84M |
| Cash from discontinued investing activities | -116.44%-7.45M | -16.21%-7.09M | -99.67%50K | -39.19%45.34M | -127.65%-6.1M | 15.29M | ||||
| Operating cash flow | 15.19%-237.48M | 49.31%-35.72M | 28.12%-42.51M | 41.93%-40.24M | -46.71%-119.01M | -50.31%-280.02M | -28.98%-70.47M | -49.61%-59.13M | -88.28%-69.3M | -46.63%-81.12M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 165.51%99.33M | -341.79%-80.31M | 163.31%46.13M | 221.47%28.61M | 383.21%104.9M | -365.78%-151.63M | 50.47%-18.18M | -822.85%-72.86M | 39.76%-23.55M | -211.68%-37.04M |
| Net PPE purchase and sale | ---- | ---- | --0 | -2,633.33%-82K | --0 | ---- | ---- | ---10K | ---3K | -380.92%-630K |
| Net intangibles purchase and sale | -143.35%-101.21M | -75.17%-9.64M | -66.64%-8.19M | -1,906.55%-76.91M | 76.35%-6.47M | -46.62%-41.59M | -32.11%-5.51M | 35.49%-4.92M | 66.50%-3.83M | -432.26%-27.34M |
| Net investment purchase and sale | 283.40%200.58M | -459.04%-70.71M | 179.96%54.32M | 635.59%105.6M | 1,327.56%111.36M | -3,120.47%-109.37M | 60.36%-12.65M | -483.53%-67.93M | 28.65%-19.72M | -123.61%-9.07M |
| Net other investing changes | 94.01%-40K | ---- | ---- | ---- | ---- | 15.55%-668K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 78.08%99.33M | -373.80%-80.31M | -65.40%46.13M | 221.47%28.61M | 383.21%104.9M | 271.34%55.78M | 53.82%-16.95M | 1,222.73%133.32M | 39.76%-23.55M | -211.68%-37.04M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -36.66%139.42M | 36,223.50%139.12M | 112.30%46K | -69.03%782K | -100.24%-525K | 83.37%220.13M | -66.84%383K | -109.01%-374K | 203.85%2.53M | 91.02%217.6M |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | -29.53%134.74M | --134.74M | --0 | --0 | --0 | 878.25%191.2M | --0 | --0 | ---1K | 878.25%191.2M |
| Proceeds from stock option exercised by employees | -78.14%6.78M | 440.31%4.91M | 278.15%571K | -57.16%1.31M | --0 | 310.37%31.04M | -45.95%908K | -95.57%151K | 29.61%3.05M | 21,970.49%26.93M |
| Net other financing activities | 0.00%-2.1M | 0.00%-525K | 0.00%-525K | 0.00%-525K | 0.00%-525K | 82.47%-2.1M | 0.00%-525K | -170.38%-525K | 65.53%-525K | 95.08%-525K |
| Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 44.25%-1.38M | 57.12%-259K | -260K | -259K | -604K |
| Financing cash flow | -36.26%139.42M | 112,092.74%139.12M | 107.26%46K | -65.49%782K | -100.24%-525K | 86.06%218.75M | -77.50%124K | -127.83%-634K | 172.68%2.27M | 90.49%217M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.69%58.18M | -74.76%36.41M | -54.44%32.29M | -73.20%43.25M | -5.69%58.18M | -62.78%61.69M | -4.69%144.24M | -60.57%70.87M | -37.10%161.38M | -62.78%61.69M |
| Current changes in cash | 123.16%1.27M | 126.45%23.09M | -95.02%3.67M | 88.02%-10.85M | -114.80%-14.63M | 94.58%-5.49M | 3.85%-87.3M | 370.72%73.55M | -20.66%-90.58M | 7.72%98.84M |
| Effect of exchange rate changes | -146.09%-913K | -178.31%-964K | 351.67%453K | -232.93%-109K | -134.55%-293K | 170.90%1.98M | 7.89%1.23M | 85.65%-180K | 104.71%82K | 190.31%848K |
| End cash Position | 0.62%58.54M | 0.62%58.54M | -74.76%36.41M | -54.44%32.29M | -73.20%43.25M | -5.69%58.18M | -5.69%58.18M | -4.69%144.24M | -60.57%70.87M | -37.10%161.38M |
| Free cash flow | -5.31%-338.69M | 39.89%-45.28M | 20.86%-50.7M | -60.31%-117.24M | -15.02%-125.47M | -49.83%-321.61M | -28.46%-75.34M | -35.42%-64.06M | -51.99%-73.13M | -80.05%-109.08M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.